Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Doxorubicin response in a triple negative breast cancer cell model: long-term resistance versus short-term stress

ABSTRACT: Doxorubicin response in a triple negative breast cancer cell model: long-term resistance versus short-term stress

PROVIDER: PRJNA836497 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Doxorubicin response in a triple negative breast cancer cell model: long-term resistance versus short-term stress

Project description:We have used a cell model for triple negative breast cancer, CAL51 cells, to study the transcriptional profiling of chemotherapy drug response. A doxorubicin resistant derivative has been generated, named CALDOX, which is able to proliferate in the continuos presence of 0.4 micro molar doxorubicin in the culture medium. In addition, both naive CAL51 and drug resistant CALDOX cells, the short-term response to doxorubicin treatment has been studied.

2023-02-27 | GSE202536 | GEO

Dynamics of Short-term transcriptomic response of S. cerevisiae to doxorubicin

Project description:Dynamics of short-term effects of doxorubicin, a chemotherapy agent, on S. cerevisiae cells were investigated. After five residence times at steady-state, Yeast cells in chemostat was introduced a doxorubicin pulse to get 20 µM initial doxorubicin concentration. Samples were collected at steady state and at 1, 5, 10, 15, 20, 25, 30, 60, 90, 120 and 180 minutes after the pulse.

2022-01-12 | E-MTAB-10023 | biostudies-arrayexpress

IL-17A increases doxorubicin efficacy in triple negative breast cancer

Project description:IL-17A increases doxorubicin efficacy in triple negative breast cancer

| PRJNA846314 | ENA

Genomic predictors of response to doxorubicin versus docetaxel in breast cancer

Project description:Low topo2a expression and ER-negative status were predictors of response to doxorubicin, while small tumor size and ER-negative status predicted response to docetaxel. Docetaxel was superior to doxorubicin in triple-negative/basal-like tumors, while no significant differences between these drugs were seen in the remaining intrinsic subtypes Keywords: reference x sample

2011-05-27 | GSE21997 | GEO

Genomic predictors of response to doxorubicin versus docetaxel in breast cancer

2011-05-27 | E-GEOD-21997 | biostudies-arrayexpress

Proteomic analysis of triple negative breast cancer cell lines

Project description:We analysed aquired chemotherapeutic resistance of two different triple negative breast cancer cell lines BT-549 (Doxorubicin resistance) and MDA-MB-468 (5-Fluorouracil) by comparing the proteome of the parental cell line with the resistant cell line.

2018-02-23 | PXD008522 | Pride

Lineage Tracing Reveals Clone-Specific Responses to Doxorubicin in Triple-Negative Breast Cancer

Project description:Triple-negative breast cancer, characterized by aggressive growth and high intratumor heterogeneity, presents a significant clinical challenge. Here, we use a lineage-tracing system, ClonMapper, which couples heritable clonal identifying tags with single-cell RNA-sequencing (scRNA-seq), to better elucidate the response to doxorubicin in a model of TNBC. We demonstrate that, while there is a dose-dependent reduction in overall clonal diversity, there is no pre-existing resistance signature among surviving clones. Separately, we found the existence of two transcriptomically distinct clonal subpopulations that remain through the course of treatment. Among clones persisting across multiple samples we identified divergent phenotypes, suggesting a response to treatment independent of clonal identity. Finally, a subset of clones harbor novel changes in expression following treatment. The clone and sample specific responses to treatment identified herein highlight the need for better personalized treatment strategies to overcome tumor heterogeneity.

2025-03-18 | GSE291679 | GEO

Short-term intensive fasting rejuvenates erythropoiesis

Project description:Short-term intensive fasting rejuvenates erythropoiesis

| PRJNA827182 | ENA

Short term perturbation

Project description:Study of the short term (within the first 330 seconds) transcriptional response of S.cerevisiae upon a sudden addition of glucose. Keywords: glucose pulse, chemostat culture, glucose catabolite repression

2005-12-16 | GSE3821 | GEO

IL-17A increases doxorubicin efficacy in triple negative breast cancer [bulk RNA-seq]

Project description:IL-17A increases doxorubicin efficacy in triple negative breast cancer [bulk RNA-seq]

| PRJNA846318 | ENA